Basic Information
CatchMabs Develops iMabA® Technology (Industrial Molecular Affinity Bodies), a Small Designed Protein Capable of Binding Target Molecules with High Affinity and High Specificity, Offering One-Step Purification for Large-Scale Processes in the Pharmaceutical and Food Processing Industries. Monoclonal Antibodies Can Be Optimized for Specific Process Conditions and Reused After the Recovery of Captured Target Molecules.